Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering
Sponsor: Beth Israel Deaconess Medical Center
Listed as NCT03370562, this NA trial focuses on Nausea and Vomiting, Postoperative and Shivering and remains completed. Sponsored by Beth Israel Deaconess Medical Center, it has been updated 9 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2021 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Not Yet Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Mar 2020 — Jun 2020 [monthly]
Not Yet Recruiting NA
-
Mar 2019 — Mar 2020 [monthly]
Not Yet Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Not Yet Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Beth Israel Deaconess Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .